83160-03-6

Upstream product

• 300594-05-2 4-[2-Oxo-3-(toluene-4-sulfonyl)-oxazolidin-(4E)-ylidene]-butyraldehyde 
• 912806-75-8 (R)-(-)-N-tosyl-4-(4',4'-diethoxybutyl)-1,3-oxazolidin-2-one 
• 912806-73-6 (E)-N-tosyl-4-(4',4'-diethoxybutylidene)-1,3-oxazolidin-2-one 
• 34404-32-5 (R)-2-amino-6-(((benzyloxy)carbonyl)amino)hexanoic acid 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 83160-10-5 N^α-Tos-D-Lys-Gly-Phe-Leu-OH 
• 83160-12-7 N^α-Tos-D-Lys-Gly-Phe-D-Leu-OH 
• 83160-13-8 N^α-Tos-D-Lys-Gly-Phe-OH 
• 83160-11-6 (3S,6S,12R)-12-Amino-6-benzyl-3-isobutyl-1,4,7,10-tetraaza-cyclohexadecane-2,5,8,11-tetraone 
• 83160-11-6 (3R,6S,12R)-12-Amino-6-benzyl-3-isobutyl-1,4,7,10-tetraaza-cyclohexadecane-2,5,8,11-tetraone 
• 83160-14-9 (3S,9R)-9-Amino-3-benzyl-1,4,7-triaza-cyclotridecane-2,5,8-trione 

Relevant academic research and scientific papers

Highly enantioselective hydrogenation of exocyclic double bond of N-tosyloxazolidinones catalyzed by a neutral rhodium complex and its synthetic applications

A highly enantioselective synthesis of optically active N-tosyl-4-alkyl-1,3-oxazolidin-2-ones based on the asymmetric hydrogenation of the trisubstituted exocyclic double bond of N-tosyl-4-alkylidene-1,3-oxazolidin-2-ones under the catalysis of neutral [R

Synthesis and Pharmacological Characterization in Vitro of Cyclic Enkephalin Analogues: Effect of Conformational Constraints on Opiate Receptor Selectivity

Using a combination of solid-phase and solution methods, we synthesized a series of cyclic 5> enkephalin analogues by substitution of D-α,ω-diamino acids in position 2 of the enkephalin sequence and cyclization of the ω-amino group to the C